SE5-24052-97633 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-22
Dose 1 — Pfizer-BioNTech
2021-01-16
Dose 2 — Pfizer-BioNTech
2021-01-20
Registered in v-safe
2021-01-23
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-09
Survey response — day 21, dose 2
MedDRA: Lymphadenopathy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Swollen ancillary lymph node in the arm that I received since the second vaccine. Slowly going down in size but still present. Had forgotten to report previously.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-09
Report sent to call center — day 21, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-26
Call 1 — Left Voicemail
2021-04-19
Survey response — 3 months, dose 2
MedDRA: Lymphadenopathy, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Unresolved axillary lymphadenopathy. Upon initial presentation, I went to a walk-in clinic. At 7 weeks, I followed up with my PCP. With the continued lack of resolution, I plan to follow up with a specialist.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-19
Report sent to call center — 3 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-21
Call 1 — Left Voicemail
2021-04-22
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-22	Pfizer-BioNTech
2	2021-01-16	Pfizer-BioNTech

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 3 — day 21, dose 2

2021-02-09

Symptoms: Swollen ancillary lymph node in the arm that I received since the second vaccine. Slowly going down in size but still present. Had forgotten to report previously.

Release 7 — 3 months, dose 2

2021-04-19

Symptoms: Unresolved axillary lymphadenopathy. Upon initial presentation, I went to a walk-in clinic. At 7 weeks, I followed up with my PCP. With the continued lack of resolution, I plan to follow up with a specialist.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Lymphadenopathy	✓	✓	✓
SD	Office visit	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release